A-770041 |
Inhibitor of LCK
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| LCK |
|
|
Inhibitor
Potentiation of paclitaxel and doxorubicin was tested using 4 nM-10 uM in U-2OSMR and KHOSR2.
1-10 uM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
A-770041 is 300-fold selective against Fyn, the other Src-family kinase involved in T-cell signal ...
Potency Cellular
In Vitro
LCK
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1016/j.bmcl.2005.09.039
In Vivo Validations
Mouse, Rat
Dose: 10 mg/Kg PO, 5 mg/Kg IV
Route of delivery:
Intravenous, Oral
Plasma half life:
4.7 (M), 4.1 (R) h
Systemic clearance:
1.5 (M), 0.2 (R) L/h/Kg
DOI Reference: 10.1016/j.bmcl.2005.09.039
Orthogonal Probes def
WH-4-023
Chemical Information
| Molecular Formula | C34H39N9O3 |
| SMILEs | COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C |
| InChI | InChI=1S/C34H39N9O3/c1-21(44)41-14-16-42(17-15-41)24-9-11-25(12-10-24)43-33-30(32(35)36-20-37-33)31(39-43)23-8-13-26(29(19-23)46-3)38-34(45)28-18-22-6-4-5-7-27(22)40(28)2/h4-8,13,18-20,24-25H,9-12,14-17H2,1-3H3,(H,38,45)(H2,35,36,37)/t24-,25- |
| Molecular weight | 621.32 Da |
| AlogP | 4.4759 |
| HBond acceptors | 12 |
| HBond donors | 3 |
| Atoms | 85 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.